SCHEMBL23722908

SCHEMBL23722908

CN(C)c1ccc(NC(=O)c2cc(-c3ccccc3)nc3ccccc23)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 11/20 1.00
MEN1 O00255 2/20 0.76
KMT2A Q03164 2/20 0.76
CYP2C9 P11712 3/20 0.67
CA12 O43570 1/20 0.67
CA1 P00915 1/20 0.67
CA2 P00918 1/20 0.67
CA9 Q16790 1/20 0.67
MAPT P10636 3/20 0.66
KDM4E B2RXH2 2/20 0.66
CNR1 P21554 2/20 0.66
CYP1A2 P05177 1/20 0.64
CYP2D6 P10635 1/20 0.64
CYP2C19 P33261 1/20 0.64
PTGER4 P35408 1/20 0.62
ALDH1A1 P00352 1/20 0.61
LMNA P02545 1/20 0.61
HTT P42858 1/20 0.61
GPR55 Q9Y2T6 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13253442 0.89 CYP3A4 (0.80) CYP3A4MEN1KMT2ACYP2C9CA12
SCHEMBL14970875 0.87 CYP3A4 (1.00) CYP3A4MEN1KMT2ACYP2C9CA12
SCHEMBL17689194 0.83 CYP3A4 (0.77) CYP3A4MEN1KMT2ACYP2C9CA12
SCHEMBL28459418 0.82 DHODH (0.74) CYP3A4KMT2AKDM4EALDH1A1LMNA
SCHEMBL14970865 0.81 CYP3A4 (0.81) CYP3A4MEN1KMT2ACYP2C9CA12
SCHEMBL16783170 0.81 KDM4E (0.77) CYP3A4MEN1KMT2ACYP2C9CA12
SCHEMBL17681381 0.81 MAPT (0.79) CYP3A4MEN1KMT2ACYP2C9CA12
SCHEMBL14970890 0.81 CYP3A4 (0.78) CYP3A4MEN1KMT2AMAPTKDM4E
SCHEMBL17689196 0.80 CYP3A4 (0.77) CYP3A4MEN1KMT2ACYP2C9MAPT
SCHEMBL17689211 0.79 KDM4E (1.00) CYP3A4MEN1KMT2ACYP2C9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210244721-A1 SMALL MOLECULE ENTEROVIRUS INHIBITORS AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210244721-A1 SMALL MOLECULE ENTEROVIRUS INHIBITORS AND USES THEREOF AR, KLK3, BRDT CYP3A4 856/4885MEN1 56/4885KMT2A 917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.